Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 4:19:619-632.
doi: 10.2147/COPD.S444888. eCollection 2024.

Prognostic Value of Leukocyte-Based Risk Model for Acute Kidney Injury Prediction in Critically Ill Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

Affiliations

Prognostic Value of Leukocyte-Based Risk Model for Acute Kidney Injury Prediction in Critically Ill Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

Min Cai et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Purpose: Acute kidney injury (AKI) is a common complication of acute exacerbation of chronic obstructive pulmonary disease (AECOPD), and inflammation is the potential link between AKI and AECOPD. However, little is known about the incidence and risk stratification of AKI in critically ill AECOPD patients. In this study, we aimed to establish risk model based on white blood cell (WBC)-related indicators to predict AKI in critically ill AECOPD patients.

Material and methods: For the training cohort, data were taken from the Medical Information Mart for eICU Collaborative Research Database (eICU-CRD) database, and for the validation cohort, data were taken from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. The study employed logistic regression analysis to identify the major predictors of WBC-related biomarkers on AKI prediction. Subsequently, a risk model was developed by multivariate logistic regression, utilizing the identified significant indicators.

Results: Finally, 3551 patients were enrolled in training cohort, 926 patients were enrolled in validation cohort. AKI occurred in 1206 (33.4%) patients in training cohort and 521 (56.3%) patients in validation cohort. According to the multivariate logistic regression analysis, four WBC-related indicators were finally included in the novel risk model, and the risk model had a relatively good accuracy for AKI in the training set (C-index, 0.764, 95% CI 0.749-0.780) as well as in the validation set (C-index, 0.738, 95% CI: 0.706-0.770). Even after accounting for other models, the critically ill AECOPD patients in the high-risk group (risk score > 3.44) still showed an increased risk of AKI (odds ratio: 4.74, 95% CI: 4.07-5.54) compared to those in low-risk group (risk score ≤ 3.44). Moreover, the risk model showed outstanding calibration capability as well as therapeutic usefulness in both groups for AKI and ICU mortality and in-hospital mortality of critical ill AECOPD patients.

Conclusion: The novel risk model showed good AKI prediction performance. This risk model has certain reference value for the risk stratification of AECOPD complicated with AKI in clinically.

Keywords: acute exacerbation of chronic obstructive pulmonary disease; acute kidney injury; prediction; risk model; white blood cell.

PubMed Disclaimer

Conflict of interest statement

Min Cai and Yue Deng are co-first authors for this study. The authors declare that they have no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The flow chart of this study.
Figure 2
Figure 2
The correlations between risk score with other serum inflammatory biomarkers, severity score, and clinical outcomes in the training set (A) and in the validation set (B). *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 3
Figure 3
The waterfall plots and forest plots of the high-risk group and low risk group for the prediction of acute kidney injury and acute respiratory failure for patients in the training set. The waterfall plot of risk score for each patient of acute kidney injury (A) and acute respiratory failure (B). The subgroup analysis of the risk score in individuals for acute kidney injury and acute respiratory failure (C).
Figure 4
Figure 4
The waterfall plots and forest plots of the high-risk group and low risk group for the prediction of in-hospital mortality and ICU mortality in the training set. The waterfall plot of risk score for each patient of in-hospital mortality (A) and ICU mortality (B). The subgroup analysis of the risk score in individuals for in-hospital mortality and ICU mortality (C).
Figure 5
Figure 5
The risk score was established to detect the ICU mortality of patients in the training set. All patients were distinguished into high and low risk based on the risk score (A), the relationship between survival time and prognosis of patients in the two corresponding groups (B), and the heatmap of WBC-based markers between the two groups (C). Receiver operating characteristic (ROC) curve analysis of the risk score for ICU mortality (D), Decision curve analysis of the risk score for ICU mortality (E). Kaplan–Meier curves showing the ICU mortality of groups with different risk (F).
Figure 6
Figure 6
The risk score was established to detect the in-hospital mortality of patients in the training set. All patients were distinguished into high and low risk based on the risk score (A), the relationship between survival time and prognosis of patients in the two corresponding groups (B), and the heatmap of WBC-based markers between the two groups (C). Receiver operating characteristic (ROC) curve analysis of the risk score for in-hospital mortality (D), Decision curve analysis of the risk score for in-hospital mortality (E). Kaplan–Meier curves showing the in-hospital mortality of groups with different risk (F).

Similar articles

Cited by

References

    1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3):1700214. doi:10.1183/13993003.00214-2017 - DOI - PubMed
    1. Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO - DOI - PMC - PubMed
    1. Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–797. doi:10.1001/jama.2019.0131 - DOI - PubMed
    1. Crisafulli E, Barbeta E, Ielpo A, Torres A. Management of severe acute exacerbations of COPD: an updated narrative review. Multidiscip Respir Med. 2018;13:36. doi:10.1186/s40248-018-0149-0 - DOI - PMC - PubMed
    1. Pickkers P, Darmon M, Hoste E, et al. Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intensive Care Med. 2021;47(8):835–850. doi:10.1007/s00134-021-06454-7 - DOI - PMC - PubMed

MeSH terms